4//SEC Filing
HedgePath Pharmaceuticals, Inc. 4
Accession 0000899243-17-007152
$INTICIK 0001042418operating
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:16 PM ET
Size
8.6 KB
Accession
0000899243-17-007152
Insider Transaction Report
Form 4
VIRCA NICHOLAS J
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2017-03-08+15,041,738→ 15,041,738 total - Tax Payment
Common Stock
2017-03-08$0.34/sh−6,314,219$2,146,834→ 8,727,519 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−15,041,738→ 0 total→ Common Stock (15,041,738 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- [F2]The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms.
Documents
Issuer
HedgePath Pharmaceuticals, Inc.
CIK 0001042418
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042418
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:16 PM ET
- Size
- 8.6 KB